Related references
Note: Only part of the references are listed.Knockdown of ANT2 reduces adipocyte hypoxia and improves insulin resistance in obesity
Jong Bae Seo et al.
NATURE METABOLISM (2019)
An Integrated View of Immunometabolism
Yun Sok Lee et al.
CELL (2018)
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Daniel J. Drucker
CELL METABOLISM (2018)
Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance
Devram S. Ghorpade et al.
NATURE (2018)
Discovery, characterization, and clinical development of the glucagon-like peptides
Daniel J. Drucker et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
Christian Baumeier et al.
MOLECULAR METABOLISM (2017)
Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis
Erin E. Mulvihill et al.
CELL METABOLISM (2017)
HIF2α Is an Essential Molecular Brake for Postprandial Hepatic Glucagon Response Independent of Insulin Signaling
Sadeesh K. Ramakrishnan et al.
CELL METABOLISM (2016)
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk
Jennifer H. Stern et al.
CELL METABOLISM (2016)
Glucagon is the key factor in the development of diabetes
Young H. Lee et al.
DIABETOLOGIA (2016)
Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes
Hannes Manell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
C/EBP homologous protein modulates liraglutide-mediated attenuation of non-alcoholic steatohepatitis
Khalidur Rahman et al.
LABORATORY INVESTIGATION (2016)
GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study
Kristine Faerch et al.
DIABETES (2015)
Increased Adipocyte O2 Consumption Triggers HIF-1α, Causing Inflammation and Insulin Resistance in Obesity
Yun Sok Lee et al.
CELL (2014)
GLP-1 Responses Are Heritable and Blunted in Acquired Obesity With High Liver Fat and Insulin Resistance
Niina Matikainen et al.
DIABETES CARE (2014)
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Philippe A. Halban et al.
DIABETES CARE (2014)
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
Erin E. Mulvihill et al.
ENDOCRINE REVIEWS (2014)
Therapies for inter-relating diabetes and obesity - GLP-1 and obesity
Eva W. Iepsen et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells
Diana Roehrborn et al.
FEBS LETTERS (2014)
Deletion of Hypoxia-Inducible Factor-1α in Adipocytes Enhances Glucagon-Like Peptide-1 Secretion and Reduces Adipose Tissue Inflammation
Yoshitaka Kihira et al.
PLOS ONE (2014)
The Fractalkine/CX3CR1 System Regulates β Cell Function and Insulin Secretion
Yun Sok Lee et al.
CELL (2013)
GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE(-/-) Mice
Naim Panjwani et al.
ENDOCRINOLOGY (2013)
Selective Inhibition of Hypoxia-Inducible Factor 1α Ameliorates Adipose Tissue Dysfunction
Kai Sun et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes
Cullen M. Taniguchi et al.
NATURE MEDICINE (2013)
Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity
F. K. Knop et al.
DIABETES OBESITY & METABOLISM (2012)
The Differential Role of Hif1 β/Arnt and the Hypoxic Response in Adipose Function, Fibrosis, and Inflammation
Kevin Y. Lee et al.
CELL METABOLISM (2011)
Disruption of Hypoxia-Inducible Factor 1 in Adipocytes Improves Insulin Sensitivity and Decreases Adiposity in High-Fat Diet-Fed Mice
Changtao Jiang et al.
DIABETES (2011)
Inflammation Is Necessary for Long-Term but Not Short-Term High-Fat Diet Induced Insulin Resistance
Yun Sok Lee et al.
DIABETES (2011)
Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
Daniela Lamers et al.
DIABETES (2011)
Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
Jens J. Holst et al.
DIABETES CARE (2011)
Physiological and Pharmacological Mechanisms through which the DPP-4 Inhibitor Sitagliptin Regulates Glycemia in Mice
Aurelie Waget et al.
ENDOCRINOLOGY (2011)
Hepatocyte-Specific Hypoxia-Inducible Factor-1α Is a Determinant of Lipid Accumulation and Liver Injury in Alcohol-Induced Steatosis in Mice
Bharath Nath et al.
HEPATOLOGY (2011)
Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced bya high-fat diet in nonalcoholic steatohepatitis
Gianluca Svegliati-Baroni et al.
LIVER INTERNATIONAL (2011)
How does PKM zeta maintain long-term memory?
Todd C. Sacktor
NATURE REVIEWS NEUROSCIENCE (2011)
GLP-1 Analogs Reduce Hepatocyte Steatosis and Improve Survival by Enhancing the Unfolded Protein Response and Promoting Macroautophagy
Shvetank Sharma et al.
PLOS ONE (2011)
Macrophages, Inflammation, and Insulin Resistance
Jerrold M. Olefsky et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions
L. Pala et al.
DIABETIC MEDICINE (2010)
Glucagon-Like Peptide-1 Receptor Is Present on Human Hepatocytes and Has a Direct Role in Decreasing Hepatic Steatosis In Vitro by Modulating Elements of the Insulin Signaling Pathway
Nitika Arora Gupta et al.
HEPATOLOGY (2010)
GIP and GLP-1, the two incretin hormones: Similarities and differences
Yutaka Seino et al.
JOURNAL OF DIABETES INVESTIGATION (2010)
Reduced liver fibrosis in hypoxia-inducible factor-1α-deficient mice
Jeon-Ok Moon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
HIF-1α is necessary to support gluconeogenesis during liver regeneration
Toshihide Tajima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Hypoxia-Inducible Factor 2 Regulates Hepatic Lipid Metabolism
Erinn B. Rankin et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
Failure to prolyl hydroxylate hypoxia-inducible factor α phenocopies VHL inactivation in vivo
William Y. Kim et al.
EMBO JOURNAL (2006)
Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26
Holger K. Eltzschig et al.
BLOOD (2006)
Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB
Stilla Frede et al.
BIOCHEMICAL JOURNAL (2006)
Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice
XK Ding et al.
HEPATOLOGY (2006)
Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice
B Ahrén et al.
DIABETOLOGIA (2005)
Molecular mechanism of hypoxia-mediated hepatic gluconeogenesis by transcriptional regulation
JH Choi et al.
FEBS LETTERS (2005)
Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects
JJ Meier et al.
DIABETES (2004)
Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region
D Dardevet et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance
SL Conarello et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs
M Nishizawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
The influence of GLP-1 on glucose-stimulated insulin secretion -: Effects on β-cell sensitivity in type 2 and nondiabetic subjects
LL Kjems et al.
DIABETES (2003)
Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects
T Vilsboll et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Reduced postprandial concentrations of intact biologically active gluccagon-like peptide 1 in type 2 diabetic patients
T Vilsboll et al.
DIABETES (2001)
Share Paper
